BPL Medical Technologies announced the acquisition of Yozma BMTech Co., Ltd., a South Korea-based company specialising in bone mineral density (BMD) diagnostic solutions, marking its entry into the bone densitometry segment. The acquisition is aimed at strengthening the company’s imaging and preventive diagnostics portfolio while expanding its capabilities in bone health assessment and early disease detection.
Following the acquisition, BPL Medical Technologies has introduced BMtech’s bone mineral density measuring systems in India and Dubai to support early screening and monitoring of osteoporosis and other bone-related conditions. The system integrates high-speed scanning and high-resolution imaging technologies while maintaining low radiation exposure to enhance patient safety.
The model supports whole-body bone densitometry and body composition analysis, which the company said can support preventive health assessments. It also incorporates fan-beam technology with multi-channel detectors designed to measure bone density across multiple anatomical sites.
The system features a compact design intended for installation in hospitals and diagnostic centres with limited space. According to the company, the introduction of the technology is intended to address increasing demand for preventive diagnostics driven by ageing populations, rising prevalence of osteoporosis, and lifestyle-related risk factors.
“This acquisition represents a significant step in strengthening our preventive healthcare and diagnostics portfolio. Bone health, particularly among women and aging populations, requires greater focus on early detection and monitoring. By bringing advanced bone mineral density technology to key markets, we aim to improve access to reliable screening solutions and support better clinical outcomes,” said Shravan Subramanyam, Managing Director of BPL Medical Technologies.
In addition to the acquisition, BPL Medical Technologies announced its entry into the computed tomography (CT) and magnetic resonance imaging (MRI) segment through a partnership with Wandong Medical. The company also introduced BPL Cortex RADS AI, developed in partnership with 5C Network, which integrates artificial intelligence into imaging workflows to support radiologists in high-volume clinical environments.
BPL Medical Technologies, headquartered in Bengaluru, manufactures medical diagnostic and imaging equipment including patient monitoring systems, imaging solutions, and critical care devices for hospitals and diagnostic centres.
